Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 10/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.36 |
| ▸ | RAF1 | P04049 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6169959 | 0.76 | MAPT (0.46) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL6168149 | 0.75 | MAPT (0.45) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL6168671 | 0.75 | ALDH1A1 (0.45) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL6168156 | 0.67 | EPHX2 (0.41) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL6172128 | 0.67 | EPHX2 (0.41) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL6168479 | 0.66 | EPHX2 (0.40) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL6168198 | 0.66 | EPHX2 (0.40) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL7844980 | 0.66 | KDM4E (0.50) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL29098671 | 0.65 | GAA (0.70) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL10362736 | 0.65 | GAA (0.70) | EPHX2EPHX1HTTALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1163236-B1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMA (US) | 2005-11-09 | — | — | EP | disclosed |
| US-6476023-B1 | Aromatic heterocyclic compounds as anti-inflammatory agents | BOEHRINGEN INGELHEIM PHARMACEUTICALS, INC. | 2002-11-05 | — | — | US | disclosed |
| EP-1163236-A1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2001-12-19 | — | — | EP | disclosed |
| US-6297381-B1 | INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES SUCH AS INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, UREAS OR THIOUREAS SUBSTITUTED BY A PYRROLE OR THIOPHENE | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2001-10-02 | — | — | US | disclosed |
| WO-2000055152-A1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | disclosed |